Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2011; 17(36): 4113-4117
Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4113
Table 3 Relationship between -765 G/C COX-2 polymorphism and clinical data of patients with pancreatic cancer n (%)
GroupG+ allele(GC and GG)(n = 47)P valueG- allele(CC)(n = 38)P value
Age< 6523 (48.9)NS16 (42.1)NS
≥ 6524 (51.1)22 (57.9)
GenderMale22 (46.8)NS19 (50.0)NS
Female25 (53.2)19 (50.0)
Tumor size ≤ 3 cm17 (40.4)NS15 (39.5)NS
> 3 cm28 (59.6)23 (60.5)
TumorG1 + G227 (57.4)NS21 (55.3)NS
DifferentiationG320 (40.4)16 (42.1)
Lymph nodeAbsent28 (59.8)NS18 (47.4)NS
MetastasesPresent19 (40.4)20 (52.6)
Weight loss< 10 %30 (63.8)NS21 (55.3)NS
≥ 10%17 (36.2)17 (44.7)
SmokingYes23 (48.9)NS17 (44.7)NS
No24 (51.1)21 (55.3)
CA19-9< 37 U/mL12 (25.5)NS12 (31.6)NS
≥ 37 U/mL35 (74.5)26 (68.4)